21. Santiago D, Rosario Y, Melin K, et al. Brand-to-generic substitution of buprenorphine/naloxone sublingual film in Puerto Rico: a case study. P R Health Sci J. 2021;40 (4):192-194. 22.

Adverse events commonly observed with buprenorphine and naloxone sublingual film are oral hypoesthesia, glossodynia, oral mucosal erythema, headache, nausea, vomiting, hyperhidrosis, constipation ...